ReviewNature reviews. Neurology2017
Achievements and obstacles of remyelinating therapies in multiple sclerosis.
Martin Stangel et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
61 papers cite itlatest 60 shown
this papercites it
ReviewNature reviews. Neurology2017
Martin Stangel et al.PubMed ↗Publisher ↗
No numbers read from the abstract.